Ketllin Bragnholo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ketllin Bragnholo has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carolina Dorigoni Bini
UNICENTRO
2 shared publications - Flávio Klinpovous Kerppers
Mid-West State University,(PR), Brazil
2 shared publications - Ivo Ilvan Kerppers
Universidade Estadual do Centro-Oeste, Brazil
2 shared publications - Luiza Ferreira Cunha
Mid-West State University,(PR), Brazil
2 shared publications - Maria Elvira Ribeiro Cordeiro
University of Brasília, Federal District, Brazil
2 shared publications - Afonso Shiguemi Inouse Salgado
Natural Quanta Wellness Center
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69
Thymomodulin as an Immunomodulatory Agent in Animal Species: a Scoping Review on Animal Health Impacts, One Health Interfaces, and Translational Relevance
Thymomodulin is a thymus-derived peptide preparation with immunomodulatory properties studied in experimental and veterinary contexts. Within a One Health framework, integrating animal, human, and environmental health, enhancing animal immunity is hypothesized to aid disease prevention, reduce zoonotic transmission, and decrease antimicrobial use. This scoping review mapped evidence on thymomodulin and comparable calf thymus extracts as immunomodulators in non-human animals from 2000 to 2025, evaluating their relevance for One Health strategies. A structured literature search (1 January 2000-31 December 2025) was conducted in PubMed, Scopus, Web of Science, and SciELO, supplemented by grey literature and patent searches. Peer-reviewed studies reporting immunological or clinical outcomes in non-human animals were included; human-only studies and those lacking immune or health endpoints were excluded. Across species, thymomodulin consistently modulated innate and adaptive immunity. In fish, dietary supplementation enhanced vaccine responsiveness, antibody titers, and survival after pathogen challenge. In rodents, thymomodulin restored immune function in immunosuppressed models and accelerated pathogen clearance. In companion animals, adjunct therapy improved clinical outcomes, including increased survival and faster remission in cats with disseminated sporotrichosis, as well as improved hematological parameters in immunocompromised animals. Evidence from poultry and swine suggests enhanced vaccine-induced immunity and maternal transfer of immune protection. Overall, thymomodulin acts as an immune normalizer, reinforcing host defenses under immune compromise. These immunological benefits could potentially reduce pathogen shedding and the need for antimicrobials indirectly; however, the evidence remains heterogeneous. Standardized clinical trials and field-based studies are needed to support translation into One Health practice.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69
Open AccessThymomodulin as an Immunomodulatory Agent in Animal Species: a Scoping Review on Animal Health Impacts, One Health Interfaces, and Translational Relevance
Thymomodulin is a thymus-derived peptide preparation with immunomodulatory properties studied in experimental and veterinary contexts. Within a One Health framework, integrating animal, human, and environmental health, enhancing animal immunity is hypothesized to aid disease prevention, reduce zoonotic transmission, and decrease antimicrobial use. This scoping review mapped evidence on thymomodulin and comparable calf thymus extracts as immunomodulators in non-human animals from 2000 to 2025, evaluating their relevance for One Health strategies. A structured literature search (1 January 2000-31 December 2025) was conducted in PubMed, Scopus, Web of Science, and SciELO, supplemented by grey literature and patent searches. Peer-reviewed studies reporting immunological or clinical outcomes in non-human animals were included; human-only studies and those lacking immune or health endpoints were excluded. Across species, thymomodulin consistently modulated innate and adaptive immunity. In fish, dietary supplementation enhanced vaccine responsiveness, antibody titers, and survival after pathogen challenge. In rodents, thymomodulin restored immune function in immunosuppressed models and accelerated pathogen clearance. In companion animals, adjunct therapy improved clinical outcomes, including increased survival and faster remission in cats with disseminated sporotrichosis, as well as improved hematological parameters in immunocompromised animals. Evidence from poultry and swine suggests enhanced vaccine-induced immunity and maternal transfer of immune protection. Overall, thymomodulin acts as an immune normalizer, reinforcing host defenses under immune compromise. These immunological benefits could potentially reduce pathogen shedding and the need for antimicrobials indirectly; however, the evidence remains heterogeneous. Standardized clinical trials and field-based studies are needed to support translation into One Health practice.
- Open Access
- 18 December 2023
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 56 (4)
Quantitative and qualitative analysis of neuroinflammation by beta amyloid 1-42 toxin after treatment with resveratrol-loaded nanoparticles
Background: This study evaluated the effects of zein nanoparticles with resveratrol on neuroinflammation caused by Alzheimer’s disease. Method: The sample consisted of 30 animals divided into control (C), positive control (CP), white nanoparticles (NB), resveratrol nanoparticles (NR) and resveratrol (R) groups. The animals received 10 mg/kg of resveratrol or nanoparticles according to the group, daily, for 15 days, oral administration. Afterward, they weresubmitted to immunohistochemical (IHC) analyses. Results: the IHC showed that there was no change in the morphological brain composition in the NR and C groups. Conversely, in the CP, NB, and R groups, changes in the deposition of Anti Tau were observed. The NR group showed a normal projection of taurine in the axon, which was not presented in the same way in the other groups. The CD68 marker showed no microglial activation in the R and C groups. Quantitative analyses of Anti Beta-Amyloid in the NR group showed a statistical difference comparedto the CP, NB, and R groups, whereas the Anti Tau analysis showed a significant difference between the CP and NR groups. The CD68 marker showed a significant difference between the C and NR groups. The analysis of cytokines showed a significant difference in TNF-α between the C and CP groups, C and NB groups, CP and NR groups, and NB and NR groups. IL-6 and InF-δ showed no significant difference between all groups. IL-10 showed significant differences between the C and NR groups, C and R groups, and CP and NR groups. Conclusion: NR prevented the evolution of neuroinflammation.
- 18 December 2023
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 56 (4)
Open AccessQuantitative and qualitative analysis of neuroinflammation by beta amyloid 1-42 toxin after treatment with resveratrol-loaded nanoparticles
Background: This study evaluated the effects of zein nanoparticles with resveratrol on neuroinflammation caused by Alzheimer’s disease. Method: The sample consisted of 30 animals divided into control (C), positive control (CP), white nanoparticles (NB), resveratrol nanoparticles (NR) and resveratrol (R) groups. The animals received 10 mg/kg of resveratrol or nanoparticles according to the group, daily, for 15 days, oral administration. Afterward, they weresubmitted to immunohistochemical (IHC) analyses. Results: the IHC showed that there was no change in the morphological brain composition in the NR and C groups. Conversely, in the CP, NB, and R groups, changes in the deposition of Anti Tau were observed. The NR group showed a normal projection of taurine in the axon, which was not presented in the same way in the other groups. The CD68 marker showed no microglial activation in the R and C groups. Quantitative analyses of Anti Beta-Amyloid in the NR group showed a statistical difference comparedto the CP, NB, and R groups, whereas the Anti Tau analysis showed a significant difference between the CP and NR groups. The CD68 marker showed a significant difference between the C and NR groups. The analysis of cytokines showed a significant difference in TNF-α between the C and CP groups, C and NB groups, CP and NR groups, and NB and NR groups. IL-6 and InF-δ showed no significant difference between all groups. IL-10 showed significant differences between the C and NR groups, C and R groups, and CP and NR groups. Conclusion: NR prevented the evolution of neuroinflammation.
- 1 April 2021
- Published by Brazilian Journals in Brazilian Journal of Development
- Vol. 7 (4) , 43616-43634
Quercetin action on pain modulation/ Ação da quercetina sobre a modulação da dor
Background: Quercetin is a flavonoid widely found in plant kingdom and target of studies in pharmacological area due to its potent antinociceptive effect compared to analgesics used in conventional therapies. The aim was to evaluate its antinociceptive activity and antinociception mechanism. Methods: For this, 40 Norvegicus Wistar rats were used, divided into 4 groups: Q50 (treated with quercetin 50 mg/Kg), Q100 (treated with quercetin 100 mg/Kg), Q500 (treated with quercetin 500 mg/Kg) and Positive control (PC) without quercetin treatment), who were submitted through the pain induction methods by tail immersion and formalin in the first step to assess antinociceptive action and in the second step, tail immersion method receiving antagonists from opioid, cholinergic and nitric oxide - L-arginine to evaluate the action mechanism. Results: Quercetin antinociceptive activity was verified at the dose of 50 mg/kg and 100 mg/kg in tail immersion test after formalin injection, with better performance at the dose of 50 mg/kg. There were no statistically significant results in paw opening and capsaicin tests. Quercetin demonstrated a possible influence on opioid and cholinergic pathway, which was not observed on the nitric acid - L-arginine pathway in view of parameters tested. Conclusion: Quercetin performed the best antinociceptive activity at a dose 50 mg/kg and there was a possible influence on opioid and cholinergic pathways.
- 1 April 2021
- Published by Brazilian Journals in Brazilian Journal of Development
- Vol. 7 (4) , 43616-43634
Quercetin action on pain modulation/ Ação da quercetina sobre a modulação da dor
Background: Quercetin is a flavonoid widely found in plant kingdom and target of studies in pharmacological area due to its potent antinociceptive effect compared to analgesics used in conventional therapies. The aim was to evaluate its antinociceptive activity and antinociception mechanism. Methods: For this, 40 Norvegicus Wistar rats were used, divided into 4 groups: Q50 (treated with quercetin 50 mg/Kg), Q100 (treated with quercetin 100 mg/Kg), Q500 (treated with quercetin 500 mg/Kg) and Positive control (PC) without quercetin treatment), who were submitted through the pain induction methods by tail immersion and formalin in the first step to assess antinociceptive action and in the second step, tail immersion method receiving antagonists from opioid, cholinergic and nitric oxide - L-arginine to evaluate the action mechanism. Results: Quercetin antinociceptive activity was verified at the dose of 50 mg/kg and 100 mg/kg in tail immersion test after formalin injection, with better performance at the dose of 50 mg/kg. There were no statistically significant results in paw opening and capsaicin tests. Quercetin demonstrated a possible influence on opioid and cholinergic pathway, which was not observed on the nitric acid - L-arginine pathway in view of parameters tested. Conclusion: Quercetin performed the best antinociceptive activity at a dose 50 mg/kg and there was a possible influence on opioid and cholinergic pathways.